tiprankstipranks
Xenetic Biosciences (XBIO)
NASDAQ:XBIO
US Market
XBIO
Xenetic Biosciences
RESEARCH TOOLSreports

Xenetic Biosciences (XBIO) Financial Statements

Compare
341 Followers

Xenetic Biosciences Financial Overview

Xenetic Biosciences's market cap is currently $6.23M. The company's EPS TTM is $; its P/E ratio is -1.38; Xenetic Biosciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 2.98M$ 2.50M$ 2.54M$ 1.71M$ 1.16M
Gross Profit$ 2.98M$ 2.50M$ 2.54M$ 1.71M$ 1.16M
Operating Income$ -2.83M$ -4.20M$ -4.52M$ -6.72M$ -5.75M
EBITDA$ -2.83M$ -4.05M$ -4.52M$ -6.69M$ -5.71M
Net Income$ -2.68M$ -3.96M$ -4.13M$ -6.55M$ -5.65M
Balance Sheet
Cash & Short-Term Investments$ 7.88M$ 6.17M$ 8.98M$ 13.10M$ 18.24M
Total Assets$ 8.36M$ 6.90M$ 10.61M$ 14.72M$ 19.82M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 27.04K
Net Debt$ -7.88M$ -6.17M$ -8.98M$ -13.10M$ -18.22M
Total Liabilities$ 968.02K$ 894.26K$ 809.59K$ 1.07M$ 1.42M
Stockholders' Equity$ 7.40M$ 6.01M$ 9.80M$ 13.65M$ 18.39M
Cash Flow
Free Cash Flow$ -2.29M$ -2.82M$ -4.11M$ -5.15M$ -4.74M
Operating Cash Flow$ -2.29M$ -2.82M$ -4.11M$ -4.65M$ -4.74M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ -500.00K$ 0.00
Financing Cash Flow$ 4.00M$ 0.00$ 0.00$ 0.00$ 11.45M
Currency in USD

Xenetic Biosciences Earnings and Revenue History

Income Statement >

Xenetic Biosciences Debt to Assets

Balance Sheet >

Xenetic Biosciences Cash Flow

Cash Flow >

Xenetic Biosciences Forecast EPS vs Actual EPS

Earnings >